Navigation Links
BioCryst Provides Update Regarding Peramivir for Influenza
Date:9/30/2009

ut/viruses/index.htm">influenza viruses. It can cause mild to severe illness, and at times can lead to death. According to the CDC, on average 5 to 20 percent of the population gets the flu in the U.S.; more than 200,000 people are hospitalized from flu complications and about 36,000 people die from flu-related causes.

More information is available at:

http://www.cdc.gov/flu/

http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan.pdf

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Limited validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's Web site at www.biocryst.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, per
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
2. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
3. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
4. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
5. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
6. BioCryst Updates Peramivir Clinical Development Plan
7. BioCryst Provides Forodesine HCl Update
8. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
9. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
10. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
11. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Inhibikase Therapeutics, Inc., an emerging leader in infectious ... new results on its antiviral program to ,prevent, ... PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, Roche ... causative agent of Progressive Multifocal Leukoencephalopathy (PML). IkT-001Pro, ... release formulation, can clear JC polyomavirus (JCV) infection ...
(Date:5/23/2013)... , May 23, 2013  PAREXEL International Corporation ... will be presenting at the Jefferies Healthcare Conference in ... Vice President and Chief Financial Officer, will be making ... 1:30 p.m. ET on Monday, June 3, 2013. ... through the "Investors" section of PAREXEL,s website at ...
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2PAREXEL International To Present At Jefferies Healthcare Conference 2Aribex Unveils New Color of NOMAD Pro 2 2
(Date:5/23/2013)... May 23, 2013 To better ... DORMA company, is pleased to announce the release ... for its pacesetting space division products. Provided by ... wallcoverings, the new patterns and colors represent a ... Through meetings with a team of Koroseal experts, ...
(Date:5/23/2013)... NY (PRWEB) May 23, 2013 A ... York Supreme Court (reference number 110504/2009) by Lori Mandel, ... verdict awarding Ms. Mandel $8.6 million. Ms. Mandel sought ... alleged misdiagnosis led to further complications that affected the ... her work. , The plaintiff alleged that her doctor ...
(Date:5/23/2013)... PETA International Science Consortium, Ltd., issued the following ... of 2013: , Reform of chemical safety legislation ... testing. , Ensuring the safety and appropriate ... Reforming the EPA,s Toxic Substances Control Act is ... Council,s vision for transforming toxicity testing "from a ...
(Date:5/23/2013)... techniques in imaging of brain activity developed by ... Institute, and his colleagues lead to improved treatment ... of electroencephalogram (EEG) and functional magnetic resonance imaging ... areas generating epileptic seizures, giving neurosurgeons a better ... appropriate. These results were presented at the ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- The success of an ... with a serious airway malformation sheds light on new technology ... report in the May 23 New England Journal of ... At first, the baby born five weeks early seemed perfectly ... when he was 6 weeks old. Just two weeks later, ...
Breaking Medicine News(10 mins):Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3
... News) -- Women, older people and minorities are under-represented in ... a new study. Researchers say that this could ... new treatments among these groups, particularly the elderly. "Our ... drugs do not represent well the U.S. population who may ...
... media fans to comment in 140 characters or less on ... toll or the great taste of a grilled cheese sandwich. ... banter, is it possible to also track important public health ... a one-word tweet: "Yes!" Mark Dredze and Michael J. ...
... A new study published in The Journal of ... such as weight problems, physical inactivity, high alcohol consumption, ... dysfunctions in men. Additionally, an unhealthy lifestyle is more ... by Associate Professor Morten Frisch, MD, PhD, DSc, of ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, July 6 ... steak or a hot fudge sundae, consider this: The high you ... one you might feel if you smoked marijuana. The ... is, a nearly irresistible desire to eat -- appears to help ...
... of bone mass during space travel and with long duration ... to an increased risk of fractures. When the final mission ... 8, an animal experiment to test a novel therapy to ... a consortium of scientists from Beth Israel Deaconess Medical Center ...
... are typically ones headed by a medical doctor rather than a ... what makes a good hospital. The research, to be published ... the first of its kind. Its conclusions run counter to ... managers -- not those with a medical degree -- at the ...
Cached Medicine News:Health News:Patient Disparities Seen in Lung Cancer Drug Trials 2Health News:You are what you tweet: Tracking public health trends with Twitter 2Health News:You are what you tweet: Tracking public health trends with Twitter 3Health News:An unhealthy lifestyle is associated with sexual dysfunction 2Health News:Binge Eating May Be a High All Its Own 2Health News:Binge Eating May Be a High All Its Own 3Health News:Experiment aboard shuttle Atlantis will test novel therapy to build bone during space travel 2Health News:The best hospitals are run by physicians 2
The cemented hip joint prosthesis system....
The uncemented hip joint prosthesis system...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: